DNAJC5 and malaria: In that study, eight variant C-terminal peptides derived from a database of naturally occurring CSP sequences in an RTS,S/AS01E phase III ancillary genotyping study (34) were tested for reactivity with sera from malaria-naïve RTS,S vaccinees (15).